Clinical Trials Logo

Filter by:
NCT ID: NCT00220740 Completed - Clinical trials for Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

ICE
Start date: April 2004
Phase: Phase 3
Study type: Interventional

The intent of this study is to demonstrate the efficacy and safety of Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in newly or previously diagnosed CIDP subjects. Eight courses of treatment with either placebo or IGIV-C will occur every 3 weeks. Neurological function will be measured by Inflammatory Neuropathy Cause and Treatment (INCAT) scores. Patients who deteriorate or show no improvement between day 16 and month 6 will receive the alternate study drug for an additional 6 months.

NCT ID: NCT00219622 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

Start date: May 2004
Phase: Phase 2
Study type: Interventional

This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease

NCT ID: NCT00214565 Terminated - Clinical trials for Diabetes Mellitus, Type 2

GALLANT 6 Tesaglitazar vs. Pioglitazone

Start date: August 2004
Phase: Phase 3
Study type: Interventional

This is a 24-week randomized, double-blind, multi-center, active-controlled (pioglitazone) study of tesaglitazar (0.5 mg and 1 mg) in patients with type 2 diabetes, not adequately controlled on diet and lifestyle advice alone during the run-in period. The study comprises a 3-week enrollment period, 6 week placebo single blind run in period followed by a 24-week double blind treatment period and a 3-week follow-up period.

NCT ID: NCT00210639 Completed - Clinical trials for Musculoskeletal Diseases

A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection

Start date: August 2002
Phase: Phase 3
Study type: Observational

The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.

NCT ID: NCT00206167 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

NCT ID: NCT00206089 Terminated - Thromboembolism Clinical Trials

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

EXTEND
Start date: September 2005
Phase: Phase 3
Study type: Interventional

This study is being carried out to study the efficacy and safety of treatment with melagatran injection followed by ximelagatran tablets in preventing blood clots, compared with enoxaparin for a period of 5-6 weeks. A separate visit, independent from the study will be done approximately 6 months after the surgery.

NCT ID: NCT00205777 Completed - Osteoporosis Clinical Trials

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Start date: December 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

NCT ID: NCT00201253 Completed - Tuberculosis Clinical Trials

Expression of Tuberculosis in the Lung

Start date: September 2000
Phase: N/A
Study type: Observational

The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.

NCT ID: NCT00198510 Completed - Clinical trials for Diabetic Retinopathy

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Start date: November 1998
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage

NCT ID: NCT00196989 Completed - Clinical trials for Diabetes Mellitus, Type 2

Study In People With Type 2 Diabetes

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This Phase 2 dose-ranging study will evaluate the efficacy, safety and tolerability of a range of doses of GW677954 compared with placebo over sixteen weeks of treatment in subjects with T2DM (Type 2 Diabetes Mellitus).